CA
NZ
UK
AU
IND
US
Orrstown Financial Services, Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the period ended September 30, 2026, and reporting total assets of $5.707 billion alongside net interest income of $53.320 million for the third quarter.
Xponential Fitness, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing a return to net income in the third quarter after nine-month losses.
Sentient Brands Holdings Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting a net loss of $62,705 for the third quarter and a nine-month net loss of $202,617.
The Elmet Group Co. filed a quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission covering the fiscal period ended October 2, 2026, disclosing balance sheet data, risk factors, and share count information as of November 4, 2026.
VAALCO Energy, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, reporting a net loss driven largely by commodity derivative losses.
Casella Waste Systems, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting a net loss of $7.021 million for the third quarter and $8.790 million for the nine months …
Viant Technology Inc. filed a Form 8-K on November 9, 2026, disclosing a $50.0 million increase to its existing stock repurchase program and announcing financial results for the three and nine months ended September 30, 2026.
Union Bankshares, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, covering third-quarter and nine-month financial results for the Vermont-based bank holding company.
Stellus Capital Investment Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 9, 2026, reporting a net decrease in net assets from operations of $6,373,879 for the third quarter.
Impact BioMedical, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing a net loss of $3,629,000 for the nine months ended September 30, 2026, with common stock not listed on a national securities exchange.
Please wait processing your request...